Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

Coria Laboratories

Status: Completed

Conditions: Healthy

Treatments: Device: Tetrix

Study type: Interventional

Funder types: Industry

Identifiers

NCT00643214

806 805 09 003

Details and patient eligibility

About

To determine if Tetrix Cream,, when applied to the skin lesions on patients with contact dermatitis, slows or interferes with the healing of the lesions.

Enrollment: 12 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Normal subjects with sensitivity to nickel.

Exclusion criteria

• Under 18 years of age.

Trial design

12 participants in 2 patient groups, including a placebo group

1

Experimental group

Description:

Twice daily topical application

Treatment:

Device: Tetrix

Device: Tetrix

2

Placebo Comparator group

Description:

Twice daily topical application

Treatment:

Device: Tetrix

Device: Tetrix

Sponsor of this trial

Lead Sponsor

Coria Laboratories